neobookRx
DrugsLevel 4 LocalisationS3VCR · VATEML

Fenticonazole

ImidazoleAntifungal

Indications

Registered South African indications:

  • Vulvovaginal candidiasis

Cautions

Contraindications

  • Hypersensitivity to the active ingredient or any of its excipients
  • Hypersensitivity to the imidazole derivatives 

Cautions

  • Pregnancy
  • Breastfeeding
  • Renal impairment
  • Hepatic impairment
  • Elderly
  • Concomitant use of barrier contraceptives

Adult dosage

Forms avail. in SA and in this monograph: cre, ovule

Vulvovaginal candidiasis

  • Topical (cre): 5g, applied intravaginally, morning and night; Treatment duration: 3 days
  • Topical (ovule): 200mg, intravaginally, dly at night; Treatment duration: 3 days
    OR
  • Topical (ovule) 600mg, as single dose, at night

Sexual partner should also be treated

Paediatric dosage

Not established for use in children

Special populations

Pregnancy

  • Caution
  • Oral administration of fenticonazole in rats has been reported to produce prolonged gestation and embryotoxic effects after doses above 40mg/kg/day. Fenticonazole does not interfere with the function of male and female gonads and does not modify the first phases of reproduction
  • Fenticonazole has shown no teratogenic effects in rats and rabbits. Fenticonazole or its metabolites cross the placental barrier in pregnant rats and rabbits after vaginal application
  • Since there is no experience of use during pregnancy, fenticonazole should not be used unless considered essential to the welfare of the patient
  • Pregnant women should not use an applicator without medical instruction

Breastfeeding

  • Caution
  • Since there is no experience of use during breastfeeding, fenticonazole should not be used by breastfeeding mothers unless it is considered essential to the welfare of the patient

Renal Impairment

Hepatic Impairment

Elderly

Porphyria Information

Drugs in Sport

  • Permitted - No warnings

Adverse reactions

Genitourinary Disorders

  • Transient vaginal burning

Immune, Blood and Lymphatic System Disorders

  • Hypersensitivity reactions

Interactions

No information available

Monitoring

None routine

Mechanism of action

Fenticonazole is a potent broad spectrum antimycotic agent. The mechanism of action of fenticonazole is thought to be the blocking of oxidant enzymes with accumulation of peroxides and necrosis of the fungal cell; direct action on the membrane.

Dosage forms

  • Vaginal cream
  • Vaginal tablet

Formulation

Vaginal cream (per 5g) 100mg

  • Lomexin (Litha Pharma) originator

Vaginal ovules 200mg

  • Lomexin (Litha Pharma) originator

Vaginal ovules 600mg

  • Lomexin (Litha Pharma) originator

References

1. SAMF_12th Edition_Page 218 2. SmPC: Gynoxin 2% vaginal cream, Recordati Pharmaceuticals Limited:Last updated on eMC: 21 Oct 2010; Downloaded online 20 Feb 2019 [https://www.medicines.org.uk/emc/medicine/23833] 3. SmPC: Gynoxin 600 mg vaginal capsules, Recordati Pharmaceuticals Limited:Last updated on eMC: 21 Oct 2010; Downloaded online 20 Feb 2019 [https://www.medicines.org.uk/emc/medicine/23831] 4. PI: Lomexin vaginalcream/200mg vaginal ovules/600mg vaginal ovules, Pharmaplan Pty Ltd:Date of registration: 14 Aug 2009 [https://drive.google.com/drive/folders/0B0xnChtF7vdubWJ3d3hzOGFvYkE] 5. NAPOS: The Drug Database for Acute Porphyria: Fenticonazole; Accessed online 20 Feb 2019 [http://www.drugs-porphyria.org/languages/UnitedKingdom/s3.php?atc_code=G01AF12&l=gbr] 6. South African Institute for Drug-Free Sport: Lomexin; Accessed online 20 Feb 2019 [http://www.drugfreesport.org.za/online-medication-check/]

Brands & products

3 products · stale NAPPI snapshot · refreshed 5/28/2026 · 159 days old

VcrGeneric· 1 product

from R11.16/unit
ProductStrengthPackSchedSEPUnitDisp feeNAPPI
Lomexin100 mg/5g30S3R334.87R11.16R117.33833908006

vaginal creamGeneric· 2 products

from R111.62/unit
ProductStrengthPackSchedSEPUnitDisp feeNAPPI
Lomexin200 mg3S3R334.87R111.62R117.33833916009
Lomexin600 mg1S3R334.87R334.87R117.33833924001
Trade names (1)
  • Lomexin

Medical aid coverage

data not yet integrated
Discovery Health
not yet integrated
  • Comprehensive Series—
  • Executive Plan—
  • KeyCare Series—
  • Priority Series—
  • Saver Series—

Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.

Bonitas Medical Fund
not yet integrated
  • BonClassic—
  • BonComprehensive—
  • BonEssential—
  • BonFit Select—
  • BonSave—
  • BonStart—

Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.

GEMS — Government Employees Medical Scheme
not yet integrated
  • Beryl—
  • Emerald—
  • Onyx—
  • Ruby—
  • Sapphire—
  • Tanzanite One—

Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.

POLMED — Police Medical Aid Scheme
not yet integrated
  • Aquarium Option—
  • Efficiency Option—
  • Marine Option—

Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.

NeoHealth® ID 15100 · updated 10/15/2022